This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
General Electric (GE) Arm Wins Wind Turbine Deal in Lithuania
by Zacks Equity Research
General Electric (GE) to offer 22 units of Cypress onshore wind turbines for European Energy's three wind farms.
Dow ETF Hits New Highs on Vaccine Optimism: 5 Best Stocks
by Sweta Killa
The Dow Jones hit all-time highs since February, marking its fastest bear market recovery in 30 years.
Crane (CR) to Benefit From Buyouts and Growth Investments
by Zacks Equity Research
Crane (CR) stands to gain from the exposure in diverse end markets, acquired assets and cost reduction initiatives.
3M's (MMM) October Sales Increase Y/Y in Low-Single Digits
by Zacks Equity Research
3M's (MMM) sales performance in October is driven by gains from acquisitions/divestitures and healthy organic performance. Businesses in geographies flourish well.
The Zacks Analyst Blog Highlights: Coca-Cola, Merck & Co, Honeywell, 3M and General Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Coca-Cola, Merck & Co, Honeywell, 3M and General Electric
Top Stock Reports for Coca-Cola, Merck & Honeywell
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Coca-Cola Company (KO), Merck (MRK) and Honeywell International (HON).
5 Reasons Why Danaher (DHR) Stock is Worth Investing in Now
by Zacks Equity Research
Danaher (DHR) to benefit from healthy growth opportunities in Life Sciences and Diagnostics segments, acquired assets and shareholders-friendly policies.
The Zacks Analyst Blog Highlights: Nike, Dow, Procter & Gamble Company, 3M and Microsoft
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, Dow, Procter & Gamble Company, 3M and Microsoft
5 Blue-Chip Stocks to Buy on Coronavirus Vaccine Hope
by Nalak Das
A COVID-19 vaccine likely to benefit the Dow the most as it is more inclined toward cyclical stocks. Five among these are NIKE (NKE), Dow (DOW), The Procter & Gamble (PG), 3M (MMM) and Microsoft (MSFT).
Can Industrial ETFs Gain Despite Mixed Q3 Earnings?
by Sweta Jaiswal, FRM
We highlight the impact of Q3 earnings releases of some major players on industrial ETFs with heavy exposure to the same.
FSS or MMM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
FSS vs. MMM: Which Stock Is the Better Value Option?
Worried About Dow's Massive Crash? ETF & Stocks to Play
by Sanghamitra Saha
Rising fears of a second wave of lockdown globally sent Wall Street crashing on Wednesday with the Dow Jones being one of the worst hurt.
Company News for Oct 28, 2020
by Zacks Equity Research
Companies In The News Are: PFE, LLY, MMM, SHW.
Wall Street Opens Green on Strong Economic Data
by Zacks Equity Research
Wall Street Opens Green on Strong Economic Data.
Markets Buoy on Durable Goods, Q3 Earnings: MRK, CAT, MMM, AMD
by Mark Vickery
Markets are up in early trading today, even though a congressional stimulus package looks kaput.
3M (MMM) Q3 Earnings Beat Estimates
by Zacks Equity Research
3M (MMM) delivered earnings and revenue surprises of 7.05% and -1.71%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
3M (MMM) Q3 Earnings Beat Estimates, Fall Y/Y on High Costs
by Zacks Equity Research
3M's (MMM) third-quarter 2020 results reflect gains from higher sales generation as well as adverse impacts of higher costs and expenses, and taxes.
General Electric (GE) to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
General Electric (GE) Q3 results are likely to reflect the impacts of the pandemic on its segmental operations. Growth in the digital business and cost measures are likely to have been tailwinds.
3M Company (MMM) to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
3M Company's (MMM) Q3 results are anticipated to reflect the impacts of healthy demand for products, growth in the geographical business, buyout gains and the lingering pandemic woes.
Bear of the Day: Carlisle (CSL)
by David Bartosiak
The stock is rocking but the earnings picture could be rolling over.
Danaher (DHR) Q3 Earnings Beat, Rise Y/Y on Sales Growth
by Zacks Equity Research
Danaher's (DHR) Q3 results reflect growth in Life Sciences and Diagnostics segments' sales, contribution from Cytiva, and operating margin rise. Core Q4 sales are likely to grow in high-single digits.
3M (MMM) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
3M (MMM) closed the most recent trading day at $169.17, moving -1.04% from the previous trading session.
Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co
by Zacks Equity Research
Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co
3M (MMM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
3M (MMM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bet on These 5 Top-Ranked Stocks With Strong Sales Growth
by Swayta Shah
Robust sales growth is an important characteristic of potential stock market winners. Let's check out - Vertex Pharmaceuticals (VRTX), PerkinElmer (PKI), Stanley Black & Decker (SWK), 3M Company (MMM) and Arthur J. Gallagher (AJG) - as these are likely to see solid sales growth.